Trial Information
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
Inclusion Criteria:
- Patients with histologically confirmed lung cancer who received standard
platinum-containing doublet chemotherapy followed by EGFR tyrosine kinase inhibitors.
Exclusion Criteria:
- non
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Principal Investigator
Hsin-Gjin Eugene Liu
Investigator Role:
Principal Investigator
Investigator Affiliation:
Taipei Medical University WanFang Hospital
Authority:
Taiwan: Department of Health
Study ID:
IRB98021
NCT ID:
NCT01141686
Start Date:
May 2009
Completion Date:
December 2009
Related Keywords:
- Lung Cancer
- lung cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms